You are here

Study Investigating Rapamune For Post-Marketing Surveillance

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Yeungnam University Medical Center
Daegu, , 705-717 Korea, Republic of
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Kidney Transplantation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
13 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects aged 13 years or older receiving renal transplants, who are newly
administered Rapamune after a contract is made between Pfizer Korea and an
investigator and/or an institution for conducting this study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any patient who does not agree that Pfizer and companies working with Pfizer use
his/her information.

- Patients who have known hypersensitivity to Rapamune or its derivatives or any
excipients in the formulation.

NCT00484094
Pfizer
Completed
Study Investigating Rapamune For Post-Marketing Surveillance

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now